Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Long-term continuous abstinence data for CYT002-NicQb

Nov. 22, 2005

No Comments

First worldwide approval for Exjade in U.S.

Nov. 3, 2005

No Comments

Radilex reduces formalin-induced lung injury

Nov. 3, 2005

No Comments

Positive opinion for oral iron chelator Exjade

Oct. 3, 2005

No Comments

Anticocaine antibody prevents death in a model of cocaine overdose

Sep. 26, 2005

No Comments

NIDA grant supports development of NicVAX

Sep. 15, 2005

No Comments

In vivo studies show efficacy for LY-379268 in opiate relapse

Sep. 15, 2005

No Comments

Lateral hypothalamus orexin neurons: new targets for addiction

Sep. 12, 2005

No Comments

Patient recruitment for phase I evaluation of N-acetylcysteine in cocaine dependence

Sep. 7, 2005

No Comments

Memantine for cocaine and tobacco addiction

Sep. 7, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Substance use and poisoning
RSS

Long-term continuous abstinence data for CYT002-NicQb

First worldwide approval for Exjade in U.S.

Radilex reduces formalin-induced lung injury

Positive opinion for oral iron chelator Exjade

Anticocaine antibody prevents death in a model of cocaine overdose

NIDA grant supports development of NicVAX

In vivo studies show efficacy for LY-379268 in opiate relapse

Lateral hypothalamus orexin neurons: new targets for addiction

Patient recruitment for phase I evaluation of N-acetylcysteine in cocaine dependence

Memantine for cocaine and tobacco addiction

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Substance use and poisoning RSS

Substance use and poisoning
RSS